Expert Insights & Commentary
BLOG
The South Florida Venture Tech Chronicle Blog goes beyond the headlines.
Here, founders, investors, and industry experts share their perspectives on emerging technologies, investment strategies, and the challenges shaping our innovation ecosystem.
Expect thought leadership, data-driven opinions, and long-form features that deepen understanding of where tech is headed next.
DermaSensor Adds $5M as AI Skin Cancer Technology Moves Into National Scale-Up
Miami-based DermaSensor has secured approximately $5 million in new financing as it advances the national commercialization of its AI-powered skin cancer assessment device. The company’s latest funding includes a $4 million Series B extension and more than $1 million from a Wefunder community investment campaign. With more than 45,000 suspicious lesions scanned and new partnerships with Henry Schein, healthcare systems, and the VA market, DermaSensor is shifting from clinical validation toward broad adoption. The milestone highlights South Florida’s growing role in medical technology and healthcare innovation.